Product Information |
|
Registration Number |
BR-1395
|
Generic Name |
Trastuzumab
|
Brand Name |
Trazimera
|
Dosage Strength |
440 mg
|
Dosage Form |
Powder For Concentrate For Solution For Infusion (IV)
|
Classification |
Prescription Drug (RX)
|
Packaging |
30 mL Type I clear glass vial with chlorobutyl rubber
stopper and aluminum crimp with flip-off cap + 20 mL Type I clear glass vial with bromobutyl rubber stopper and aluminum crimp with flip-off cap (Bacteriostatic Water for Injection as diluent) (Box of 1's)
|
Pharmacologic Category |
Monoclonal Antibodies [HER2 (Human Edpidermal Growth Factor Receptor 2) Inhibitors)
|
Manufacturer |
Pfizer Manufacturing Belgium NV
|
Country of Origin |
Belgium
|
Trader |
N/A
|
Importer |
Pfizer, Inc.
|
Distributor |
Pfizer, Inc.
|
Application Type |
Initial
|
Issuance Date |
30 March 2022
|
Expiry Date |
30 March 2027
|